Search Millennial life, simply
Curated for your stage
4Millennial is a search engine designed for people born roughly between 1981 and 1996. It blends proprietary indexes, curated content, and AI tools to surface results that match the financial, career, housing, wellness, and cultural priorities of this generation. Use the home page to explore curated features, trending searches, and links to web, news, shopping, and chat tools tailored to Millennial needs. Part of the 4SEARCH network of topic specific search engines.
Latest News & Web Pages
Reinsurance Group Of America - RZC - Stock Price & News
1+ mon, 1+ week ago (296+ words) Reinsurance Group of America, Inc. is a holding company, which engages in the provision of traditional and non-traditional life and health reinsurance products. It operates through the following segments: U. S. and Latin America, Canada, Europe, Middle East, and Africa, Asia Pacific,…...
Data Storage Corporation Unveils New Strategy Targeting Critical AI Infrastructure Gap in Regulated Industries
1+ week, 6+ day ago (825+ words) Detailed price information for Data Storage Corp WT (DTSTW-Q) from The Globe and Mail including charting and trades. Data Storage Corporation Unveils New Strategy Targeting Critical AI Infrastructure Gap in Regulated Industries Establishing Wholly Owned Subsidiary Developing AI Continuity Control…...
__symbol__ Stock Quote Price and Forecast | CNN
3+ hour, 34+ min ago (111+ words) DLHC is trading near the bottom of its 52-week range and below its 200-day simple moving average. The price of DLHC shares has held flat since the market last closed. This is a 0. 00% change. The stock has remained unchanged in…...
Analysts Are Bullish on Top Healthcare Stocks: PTC Therapeutics (PTCT), Palvella Therapeutics (PVLA)
2+ week, 2+ day ago (270+ words) There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PTC Therapeutics (PTCT) and Palvella Therapeutics (PVLA) with bullish sentiments. PTC Therapeutics received a Buy rating and a $90. 00 price target from TD Cowen…...
Braemar Hotels Extends Advisory Agreement Fee Negotiation Period
2+ day, 5+ hour ago (143+ words) Braemar Hotels & Resorts ( (BHR) ) just unveiled an announcement. The most recent analyst rating on (BHR) stock is a Hold with a $4. 00 price target. To see the full list of analyst forecasts on Braemar Hotels & Resorts stock, see the BHR Stock…...
Armata Secures New Loan Amid Wider Quarterly Loss
1+ week, 4+ day ago (128+ words) Armata Pharmaceuticals ( (ARMP) ) has provided an update. The most recent analyst rating on (ARMP) stock is a Buy with a $20. 00 price target. To see the full list of analyst forecasts on Armata Pharmaceuticals stock, see the ARMP Stock Forecast page....
Duos Edge AI to Host Lubbock Edge Data Center Open House
6+ day, 20+ hour ago (280+ words) LUBBOCK, Texas, May 19, 2026 (GLOBE NEWSWIRE) -- Duos Edge AI, Inc. (Duos Edge AI), a subsidiary of Duos Technologies Group, Inc. (Nasdaq: DUOT), will host an open house in Lubbock, Texas to showcase its newly operational Edge Data Center (EDC) infrastructure serving…...
Crescent Capital BDC Balances Fee Cuts And Credit Strain
1+ week, 3+ day ago (797+ words) Crescent Capital Bdc, Inc. ((CCAP)) has held its Q1 earnings call. Read on for the main highlights of the call. Crescent Capital BDC's latest earnings call struck a cautious but purposeful tone as management balanced credit pressures with structural moves to…...
Despite Chat GPT Integration, Upwork (UPWK) Is At Risk Of Collapsing Due To AI
1+ mon, 1+ day ago (248+ words) Peter Sanborn, chief business officer at Upwork Inc. (NASDAQ: UPWK), commented: "Human expertise paired with AI is transforming work, and this integration brings the Upwork Marketplace directly into one of the tools millions of people use to get work started....
Marker Therapeutics Highlights Strong MT-601 Data and Prepares for Key 2026 Milestones
2+ mon, 5+ day ago (128+ words) The latest update is out from Marker Therapeutics ( (MRKR) ). The most recent analyst rating on (MRKR) stock is a Sell with a $1. 50 price target. To see the full list of analyst forecasts on Marker Therapeutics stock, see the MRKR Stock…...